Nasdaq IPOs

Panacea Acquisition, a blank check company formed by EcoR1 Capital targeting the biotech industry, filed on Friday with the SEC to raise up to $125 million in an initial public offering. The company plans to raise an additional $25 million through a forward purchase agreement wit

NuZee, which packages and sells single-serve coffee products, increased the proposed share offering for its upcoming IPO on Friday. The Plano, TX-based company now plans to raise $6 million by offering 0.7 million shares at $9, the May 20th close of its shares on the OTCQB (NUZE)

Car House Holding, which operates an online B2B marketplace for car products in China, filed on Friday with the SEC to raise up to $37 million in an initial public offering. The company began its business in developing, manufacturing, and selling auto perfume and air fresheners.

Burning Rock Biotech, which provides DNA sequencing-based cancer therapy selection tests in China, raised $223 million by offering 13.5 million ADSs at $16.50, above the range of $13.50 to $15.50. Insiders had indicated on $79 million of the IPO (35% of the deal). The company rai

Vaxcyte, a preclinical biotech developing next-generation pneumococcal vaccines, raised $250 million by offering 15.6 million shares at $16, the high end of the range of $14 to $16. The company offered 1.6 million more shares than anticipated. At pricing, the company commands a f

Avidity Biosciences, a preclinical biotech developing antibody therapies for muscle disorders, raised $259 million by offering 14.4 million shares at $18, the high end of the upwardly revised range of $17 to $18. Earlier on Thursday, the La Jolla, CA-based company raised the

The AZEK Company, which manufactures composite decking materials and other building products, raised $765 million by offering 33.3 million shares at $23, above the range of $19 to $21, as indicated by an S-1MEF form filed with the SEC. The company sold 2.0 million shares mor

Generation Bio, a preclinical biotech developing gene therapies for rare diseases, raised $200 million by offering 10.5 million shares at $19, the high end of the revised range of $18 to $19. The company offered 0.5 million more shares than anticipated after upwardly revising its

GS Acquisition Holdings II, the second blank check company formed by Goldman Sachs, filed on Thursday with the SEC to raise up to $700 million in an initial public offering. The New York, NY-based company plans to raise $700 million by offering 70 million units at $10. Each unit

As indexes like the Nasdaq Composite and Nasdaq-100 hit all-time highs, there are many signs that the economy is on the road to recovery.

Lantern Pharma, a biotech redeveloping abandoned drugs for non-small cell lung cancer, raised $26 million by offering 1.8 million shares at $15, the low end of the range of $15 to $17. Lantern Pharma plans to list on the Nasdaq under the symbol LTRN. ThinkEquity acted as a lead m

Capstar Special Purpose Acquisition, a blank check company formed by investment firm Capstar Partners, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The Austin, TX-based company plans to raise $200 million by offering 20 million units a

Generation Bio, a preclinical biotech developing gene therapies for rare diseases, raised the proposed deal size for its upcoming IPO on Thursday. The Cambridge, MA-based company now plans to raise $185 million by offering 10 million shares at a price range of $18 to $19. The com

Avidity Biosciences, a preclinical biotech developing antibody therapies for muscle disorders, raised the proposed deal size for its upcoming IPO on Thursday. The La Jolla, CA-based company now plans to raise $210 million by offering 12 million shares at a price range of $17 to $

uCloudlink, a mobile data traffic sharing marketplace in China, raised $36 million by offering 2 million ADSs at $18, the low end of the range of $18.00 to $20.50. The company offered 0.6 million fewer ADSs than anticipated. At pricing, the company commands a fully diluted market

Online used car dealer Vroom (VRM) popped 118% on Tuesday, the best first-day return for a tech IPO since China's Qutoutiao (QTT; +128% pop) in September 2018. Among US-based tech IPOs, Vroom notched the best pop since Nutanix (NTNX; +131%) in September 2016.

Three large preclinical biotech IPOs are slated to begin trading on Friday, the most ever in a single week.Vaxcyte (PCVX) is developing next-generation pneumonia vaccines, a $7 billion market, and expects to begin clinical trials for its lead candidate in the 2H21. Avidity Biosci

Kensington Capital Acquisition, a blank check company targeting the automotive industry, filed on Tuesday with the SEC to raise up to $175 million in an initial public offering. The Westbury, NY-based company plans to raise $175 million by offering 17.5 million units at $10. Each

Dun & Bradstreet, which provides commercial data analytics services, filed on Tuesday with the SEC to raise up to $1.0 billion in an initial public offering. The company was taken private in February 2019 by an investor consortium led by shareholders Cannae Holdings (NYSE: CN

Hudson Executive Investment, a blank company formed by Hudson Executive Capital targeting fintech or healthcare, raised $360 million by offering 36 million shares at $10. The company originally filed to offer 30 million units. Units consist of one share of common stock and one ha